Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer.
作者信息
Yu Zhigang
机构信息
Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, China.
出版信息
Transl Breast Cancer Res. 2023 Nov 22;5:5. doi: 10.21037/tbcr-23-39. eCollection 2024.
Abstract
摘要
Zotero 插件